Školení EIZ

Na této stránce naleznete seznam školení, konferencí a webinářů a to včetně archivu akcí. Pokud je anotace v anglickém jazyce, akce bude v tomto jazyce realizována.

Speciální akce od poskytovatelů EIZ:

V současné době nejsou žádné speciální akce.

  • Elsevier webinars 2026

    11. 3. 2026 - 9. 12. 2026

    Všechny webináře včetně přihlašovacího linku najdete v dokumentu pdf.

  • Interested in a Free CAS SciFinder Discovery Platform Pilot?

    1. 10. 2026 - 30. 12. 2026

    FOR a new potential members for CAS SciFinder Discovery Platform


    Organizations active in life sciences and chemistry research are invited to explore the CAS SciFinder Discovery Platform through a free one-month pilot program. The platform enables researchers to efficiently discover, analyze, and connect scientific information across journal literature, patents, substances, reactions, and chemical suppliers, helping to accelerate research and innovation.

    To help participants gain maximum value from the pilot, CAS will organize an online webinar at the beginning of the pilot, demonstrating the platform's key features, workflows, and best practices.


    Organizations interested in participating are encouraged to contact Tetiana Khristova at tkhristova@acs-i.org to learn more and arrange their free pilot.
    Read more
  • Transparent Reporting in Clinical Research: From Registration to Publication

    6. 10. 2026

    Transparent reporting in clinical research is essential for research quality, integrity, and trust. This webinar will explore best‑practice reporting guidelines for different study types, including CONSORT, STROBE, and PRISMA, and explain why rigorous reporting matters throughout the research lifecycle. The session will also address race and ethnicity reporting, sex and gender considerations, and the journey from clinical trial registration to publication. Attendees will gain practical guidance on meeting reporting requirements, including specific considerations for article types such as systematic reviews and case reports, and learn how Wiley journals support and assess compliance with these standards.
    Registration here.

  • CAS SciFinder Discovery Platform update training session

    14. 10. 2026

    Date and time: 14 October 2026, 10:00–11:30

    The webinar, led by expert trainer Dr. Míriam Plana, will guide you through the platform’s most relevant scientific functionalities and will highlight the main differences between CAS SciFinder Discovery Platform and CAS SciFinder-n.

    The session will cover the following topics:

    • AI-interpreted natural language search
    • Accurate summarization powered by scientist-trained AI
    • Structure-based substance and reaction searches using CAS Structure Editor
    • Access and analyze substance properties and spectra. Find compounds matching specific properties or spectra
    • CAS Newton, agentic AI
    • Analytical methods and formulation searching


    Participants can ask questions during the session or follow up afterwards.


    No registration is required to attend. Join the webinar here.

  • Web of Science Research Assistant/Bezplatný trial pro instituce v České republice

    15. 10. 2026 - 31. 10. 2026

    Zveme české instituce k vyzkoušení nástroje Web of Science Research Assistant – nové generace AI asistenta dostupného přímo v platformě Web of Science.
    Více info zde.

  • Interested in a Free BioFinder Pilot?

    15. 10. 2026 - 15. 11. 2026

    FOR existing SciFinder subscribers

    Interested in a Free BioFinder Pilot?

    Organizations with an existing CAS SciFinder Discovery Platform subscription are invited to participate in a free one-month pilot of the CAS BioFinder Discovery Platform.

    BioFinder supports pre-clinical drug discovery by bringing together biological and chemical data, predictive models, bioactivity and biomarker information, and ligand-protein interaction insights in a single platform. Designed for both biologists and chemists, it helps researchers make faster, more confident decisions across discovery biology and medicinal chemistry workflows.

    To help users get the most from the pilot, an online webinar will be organized at the beginning of the pilot to introduce the platform's key features and best practices.

    For more information or to arrange a pilot, please contact Tetiana Khristova at tkhristova@acs-i.org.

  • CAS BioFinder Discovery Platform training for CzechELib

    22. 10. 2026

    Date and time: 22 October 2026, 10:00–10:45

    During this session, our expert trainer, Dr. Elena Detta, will guide you through the platform’s most relevant scientific functionalities, focusing on the following topics:

    • Explore connected data across ligands, targets and diseases. Search bioactivity data, chemical structures, sequences, biological pathways, disease biomarkers, antibodies and ADCs, and immunotherapies. All of it is drawn from thousands of life sciences journals and nearly 100 patent offices, and standardized by CAS scientists.
    • Predict where experimental data doesn't exist yet. Use AI-enhanced models to batch-screen ligands against targets and to uncover potential targets, off-target effects and polypharmacology. Each prediction comes with a confidence score and links showing the evidence behind it.
    • Ask complex questions in plain language. CAS Newton, the AI assistant built into BioFinder, returns concise, evidence-backed answers grounded in CAS human-curated content.
    • Follow a compound from the literature to the clinic. Use interactive visualizations and 3D models to navigate biologically relevant compounds, and check drug intelligence on clinical trial status, indications and targets.
    • Stay in your existing workflow. BioFinder is integrated with CAS SciFinder. You can move between chemistry and biology data without starting over.

    No registration is required to attend. Join the webinar here.
  • AI, Copyright, and Training: Ensuring Compliance in the Age of AI

    28. 10. 2026

    As organizations integrate AI into research and content workflows, copyright and re-use rights become critical concerns. How can companies ensure they're compliant when using AI tools trained on copyrighted content?
    Registration here.